ARPA-H launched SPECTRA on September 17, 2026, a research program using AI to combine biological, behavioral, and clinical data in hopes of diagnosing autism earlier and tailoring care to each child's developmental trajectory.
A Yale School of Medicine study found that fine-tuning AI models on more than 13,000 patient records raised diagnostic accuracy from 48.6 to 54.8 percent, but also made the models far more likely to memorize and potentially leak sensitive patient details.
A multinational study of 963 stroke patients in Korea and the U.S. found that AI assistance reading plain, contrast-free brain CT scans raised clinicians' detection of dangerous large vessel occlusions, catching one additional case for every 18 scans reviewed.
The VA selected Abridge on September 22, 2026 for a five-year, $775.72 million enterprise contract to expand ambient AI documentation tools across veterans' health care, building on a pilot already running in more than 75 medical centers.
Nutrition scientist Betty Murray has built an AI platform aiming to personalize menopause care and finally generate the large-scale real-world data on midlife women's health that clinical medicine has long lacked, D CEO reports.
An FDA advisory panel voted September 23, 2026 that Grail's AI-powered Galleri blood test, which screens for more than 50 cancer types via DNA methylation patterns, has benefits that outweigh its risks, moving it closer to approval.
AI-powered skin cancer scanners keep improving overall, but new analysis published September 3, 2026 shows accuracy still drops sharply for patients with darker skin, reviving debate over biased training data in dermatology AI.
Moderna and Merck announced on August 19, 2026 that their AI-designed, patient-specific mRNA melanoma vaccine met its main goals in a Phase 3 trial, the first randomized late-stage success for an individualized cancer vaccine.
A 2026 American Psychological Association survey of over 1,200 licensed psychologists found 77% have patients who discuss using AI for mental health support, while the vast majority of clinicians distrust chatbots to handle crises safely.
NHTSA opened an audit into Tesla's Cybercab the same day paid rides began in Austin on September 3, 2026, then escalated to a formal Special Order on September 10 demanding Tesla justify how it self-certified a vehicle with no steering wheel or pedals as federally compliant.